Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04660318
Other study ID # 2020-A02428-31
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 14, 2020
Est. completion date December 1, 2022

Study information

Verified date June 2021
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Introduced in 1930, photoplethysmography techniques presented the possibility of measuring SpO2 and HR using the absorption of light by the blood to define these signals In recent years, a new approach to photoplethysmography to measure physiological parameters without contact has been developed. This technique, called remote Photoplethysmography Imaging (rPPG), uses the different Red - Green - Blue color spectra at a skin captured by the camera video to determine a plethysmography signal. Although these systems have been technically valid, they have not been clinically evaluated in a health setting. This clinical trial is to assess parameters measurements by rPPG compared standard acquisition system in real conditions


Recruitment information / eligibility

Status Recruiting
Enrollment 1045
Est. completion date December 1, 2022
Est. primary completion date May 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients requiring a Pulmonary function testing. Exclusion Criteria: - Patients with stable clinical status. - Pregnant woman or Woman of childbearing potential without effective contraception

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Remote photoplethysmography for physiological parameters
physiological parameters will be acquired using the Remote photoplethysmography software simultaneously for the conventional parameters measurements (heart rate, respiratory rate, and oxygen saturation)
standard acquisition system for physiological parameters
physiological parameters will be acquired using the standard acquisition system for the conventional parameters measurements (heart rate, respiratory rate, and oxygen saturation)

Locations

Country Name City State
France Centre Hospitalier Régional Universitaire de Nancy. Vandoeuvre les nancy

Sponsors (1)

Lead Sponsor Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concordance of rPPG heart rate readings Heart rateconcordance analysis by standard acquisition system (photoplethysmography of the finger) compared rPPG 30-120 seconds.
Primary Concordance of rPPG respiratory rate readings respiratory rate concordance analysis by standard acquisition system (photoplethysmography of the finger) compared rPPG 30-120 seconds.
Primary Concordance of rPPG oxygen saturation readings oxygen saturation concordance analysis by standard acquisition system (photoplethysmography of the finger) compared rPPG 30-120 seconds.
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06203743 - Evaluation of Caudal Block and Ilioinguinal-ilioohypogastric Nerve Block Efficacy With Perfusion Index (PI) N/A